FP
Flagship Pioneering Portfolio holdings
AUM
$268M
This Quarter Return
+13.52%
1 Year Return
-54.4%
3 Year Return
-51.2%
5 Year Return
+66.7%
10 Year Return
–
AUM
$1.79B
AUM Growth
+$1.79B
(-2.1%)
Cap. Flow
-$216M
Cap. Flow
% of AUM
-12.06%
Top 10 Holdings %
Top 10 Hldgs %
100%
Holding
10
New
–
Increased
–
Reduced
2
Closed
1
Top Buys
No buys this quarter
Top Sells
| 1 |
Moderna
MRNA
|
$155M |
| 2 |
Transmedics
TMDX
|
$60.1M |
| 3 |
Denali Therapeutics
DNLI
|
$444K |
Sector Composition
| 1 | Healthcare | 100% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
Moderna
MRNA
$9.37B
| $995M | 55.62% | 50,871,524 -7,935,855 | -13% | -$155M |
|
|
RUBY
2
DELISTED
Rubius Therapeutics, Inc
RUBY
| $364M | 20.34% | 38,296,526 | – | – |
|
|
3
Denali Therapeutics
DNLI
$2.23B
| $139M | 7.77% | 7,980,263 -25,484 | -0.3% | -$444K |
|
|
KLDO
4
DELISTED
Kaleido Biosciences, Inc. Common Stock
KLDO
| $87.2M | 4.87% | 17,360,710 | – | – |
|
5
Seres Therapeutics
MCRB
$166M
| $74.4M | 4.16% | 21,571,764 | – | – |
|
|
EVLO
6
DELISTED
Evelo Biosciences, Inc. Common Stock
EVLO
| $74M | 4.14% | 18,233,403 | – | – |
|
|
AXLA
7
DELISTED
Axcella Health Inc. Common Stock
AXLA
| $35.1M | 1.96% | 8,748,414 | – | – |
|
|
SYRS
8
DELISTED
Syros Pharmaceuticals, Inc. Common Stock
SYRS
| $20.3M | 1.14% | 2,938,494 | – | – |
|
9
Quanterix
QTRX
$211M
| – | – | 0 | – | – |
|
|
10
Transmedics
TMDX
$3.92B
| – | – | -2,530,275 | Closed | -$60.1M |
|